ArticleEClinicalMedicine2023

Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials.

Paul E Sax et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.